Provided by Tiger Trade Technology Pte. Ltd.

KINTOR PHARMA-B

1.740
+0.0502.96%
Volume:50.50K
Turnover:87.82K
Market Cap:868.26M
PE:-3.35
High:1.740
Open:1.730
Low:1.730
Close:1.690
52wk High:4.700
52wk Low:1.605
Shares:499.00M
HK Float Shares:499.00M
Volume Ratio:0.94
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.519
ROE:-83.96%
ROA:-25.20%
PB:4.08
PE(LYR):-3.35
PS:22.77

Loading ...

Medical sector compliance cracks widen as military procurement probes hit major drugmakers

Deep News
·
Aug 21

Huapont Life Sciences Emphasizes R&D Commitment and AI Efficiency Initiatives

Deep News
·
Aug 20

Daily ETF Wrap: Innovative Drugs and CXO Remain the Two Brightest Investment Themes in the Healthcare Sector

Deep News
·
Aug 20

A Beginner's Guide to Biotech Stock Safety: A Framework for Identifying Red Flags

Deep News
·
Aug 20

Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib

Deep News
·
Aug 20

Medical Stocks Surge on Breakthrough News: Everest Med Jumps Over 70% Intraday, Wuxi Apptec Hits New High, and ETFs See Explosive Volume

Deep News
·
Aug 20

Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets

Deep News
·
Aug 20

Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals

Stock News
·
Aug 20

US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%

Stock News
·
Aug 20

GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials

Stock News
·
Aug 20

KINTOR PHARMA H1 2026 Loss Narrows 9% as Revenue Soars 7.67-Fold; Flagship AGA Drug KX-826 Achieves Phase III Success

Bulletin Express
·
Aug 19

Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback

Stock News
·
Aug 19

Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million

Stock News
·
Aug 19

Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million

Reuters
·
Aug 19

Kintor Pharmaceutical H1 Revenue RMB 52 Million

THOMSON REUTERS
·
Aug 19

Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation

Stock News
·
Aug 19

This Sector Is Experiencing a Major Surge

Deep News
·
Aug 19

Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up

Stock News
·
Aug 18

Puqi Pharma's Accumulated Losses Near RMB 400 Million: Net Asset Value Turns Negative, Chief Medical Officer's Compensation Surges

Deep News
·
Aug 18

TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward

Stock News
·
Aug 17